NAT10 and DDX21 Proteins Interact with RNase H1 and Affect the Performance of Phosphorothioate Oligonucleotides
Overview
Molecular Biology
Pharmacology
Affiliations
RNase H1-dependent phosphorothioate oligonucleotides (PS-ASOs) have been developed to treat various diseases through specific degradation of target RNAs. Although many factors or features of RNA and PS-ASOs have been demonstrated to affect antisense activity of PS-ASOs, little is known regarding the roles of RNase H1-associated proteins in PS-ASO performance. In this study, we report that two nucleolar proteins, NAT10 and DDX21, interact with RNase H1 and affect the potency and safety of PS-ASOs. The interactions of these two proteins with RNase H1 were determined using BioID proximity labeling in cells and confirmed biochemically. Reduction of NAT10 and DDX21 decreased PS-ASO activity in cells, and purified NAT10 and DDX21 proteins enhanced RNase H1 cleavage rates, indicating that these two proteins facilitate RNase H1 endoribonuclease activity. Consistently, reduction of these proteins increased the levels of R-loops, and impaired pre-rRNA processing. In addition, reduction of the two proteins increased the cytotoxicity of toxic PS-ASOs, and treatment of toxic PS-ASOs also altered the localization of these proteins. Together, this study shows for the first time that NAT10 and DDX21 interact with RNase H1 protein and enhance its enzymatic activity, contributing to the potency and safety of PS-ASOs.
Biological function and mechanism of NAT10 in cancer.
Han Y, Zhang X, Miao L, Lin H, Zhuo Z, He J Cancer Innov. 2025; 4(1):e154.
PMID: 39817252 PMC: 11732740. DOI: 10.1002/cai2.154.
NAT10 resolves harmful nucleolar R-loops depending on its helicase domain and acetylation of DDX21.
Su K, Zhao Z, Wang Y, Sun S, Liu X, Zhang C Cell Commun Signal. 2024; 22(1):490.
PMID: 39394182 PMC: 11468200. DOI: 10.1186/s12964-024-01869-3.
RPA transforms RNase H1 to a bidirectional exoribonuclease for processive RNA-DNA hybrid cleavage.
Li Y, Liu C, Jia X, Bi L, Ren Z, Zhao Y Nat Commun. 2024; 15(1):7464.
PMID: 39198528 PMC: 11358518. DOI: 10.1038/s41467-024-51984-5.
Regulation of the epigenome through RNA modifications.
Patrasso E, Raikundalia S, Arango D Chromosoma. 2023; 132(3):231-246.
PMID: 37138119 PMC: 10524150. DOI: 10.1007/s00412-023-00794-7.
Chemistry of Therapeutic Oligonucleotides That Drives Interactions with Biomolecules.
Terada C, Kawamoto S, Yamayoshi A, Yamamoto T Pharmaceutics. 2022; 14(12).
PMID: 36559141 PMC: 9781680. DOI: 10.3390/pharmaceutics14122647.